Logo image of NORBT.OL

NORBIT ASA (NORBT.OL) Stock Fundamental Analysis

Europe - OSL:NORBT - NO0010856511 - Common Stock

183 NOK
-7.8 (-4.09%)
Last: 9/26/2025, 7:00:00 PM
Fundamental Rating

8

Taking everything into account, NORBT scores 8 out of 10 in our fundamental rating. NORBT was compared to 54 industry peers in the Electronic Equipment, Instruments & Components industry. NORBT gets an excellent profitability rating and is at the same time showing great financial health properties. NORBT is not priced too expensively while it is growing strongly. Keep and eye on this one! These ratings would make NORBT suitable for growth and quality investing!


Dividend Valuation Growth Profitability Health

9

1. Profitability

1.1 Basic Checks

NORBT had positive earnings in the past year.
In the past year NORBT had a positive cash flow from operations.
Each year in the past 5 years NORBT has been profitable.
In the past 5 years NORBT always reported a positive cash flow from operatings.
NORBT.OL Yearly Net Income VS EBIT VS OCF VS FCFNORBT.OL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 0 100M 200M 300M 400M

1.2 Ratios

Looking at the Return On Assets, with a value of 12.76%, NORBT belongs to the top of the industry, outperforming 94.44% of the companies in the same industry.
NORBT has a better Return On Equity (24.39%) than 96.30% of its industry peers.
The Return On Invested Capital of NORBT (18.38%) is better than 96.30% of its industry peers.
The Average Return On Invested Capital over the past 3 years for NORBT is significantly above the industry average of 10.39%.
The last Return On Invested Capital (18.38%) for NORBT is above the 3 year average (17.33%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 12.76%
ROE 24.39%
ROIC 18.38%
ROA(3y)10.75%
ROA(5y)8.25%
ROE(3y)20.73%
ROE(5y)15.61%
ROIC(3y)17.33%
ROIC(5y)13.48%
NORBT.OL Yearly ROA, ROE, ROICNORBT.OL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 10 20 30

1.3 Margins

NORBT has a Profit Margin of 16.20%. This is amongst the best in the industry. NORBT outperforms 96.30% of its industry peers.
In the last couple of years the Profit Margin of NORBT has grown nicely.
NORBT's Operating Margin of 23.08% is amongst the best of the industry. NORBT outperforms 96.30% of its industry peers.
In the last couple of years the Operating Margin of NORBT has grown nicely.
NORBT has a better Gross Margin (61.99%) than 74.07% of its industry peers.
NORBT's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 23.08%
PM (TTM) 16.2%
GM 61.99%
OM growth 3Y29.01%
OM growth 5Y7.42%
PM growth 3Y31.71%
PM growth 5Y3.74%
GM growth 3Y3.52%
GM growth 5Y1.89%
NORBT.OL Yearly Profit, Operating, Gross MarginsNORBT.OL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 10 20 30 40 50

7

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so NORBT is creating value.
Compared to 1 year ago, NORBT has more shares outstanding
NORBT has more shares outstanding than it did 5 years ago.
NORBT has a worse debt/assets ratio than last year.
NORBT.OL Yearly Shares OutstandingNORBT.OL Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
NORBT.OL Yearly Total Debt VS Total AssetsNORBT.OL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

2.2 Solvency

An Altman-Z score of 8.22 indicates that NORBT is not in any danger for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 8.22, NORBT belongs to the top of the industry, outperforming 90.74% of the companies in the same industry.
NORBT has a debt to FCF ratio of 1.68. This is a very positive value and a sign of high solvency as it would only need 1.68 years to pay back of all of its debts.
With an excellent Debt to FCF ratio value of 1.68, NORBT belongs to the best of the industry, outperforming 85.19% of the companies in the same industry.
A Debt/Equity ratio of 0.41 indicates that NORBT is not too dependend on debt financing.
The Debt to Equity ratio of NORBT (0.41) is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.41
Debt/FCF 1.68
Altman-Z 8.22
ROIC/WACC2.2
WACC8.36%
NORBT.OL Yearly LT Debt VS Equity VS FCFNORBT.OL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M 800M 1B

2.3 Liquidity

NORBT has a Current Ratio of 1.93. This is a normal value and indicates that NORBT is financially healthy and should not expect problems in meeting its short term obligations.
NORBT has a better Current ratio (1.93) than 64.81% of its industry peers.
A Quick Ratio of 0.97 indicates that NORBT may have some problems paying its short term obligations.
With a Quick ratio value of 0.97, NORBT perfoms like the industry average, outperforming 48.15% of the companies in the same industry.
The current and quick ratio evaluation for NORBT is rather negative, while it does have excellent solvency and profitability. These ratios do not necessarly indicate liquidity issues and need to be evaluated against the specifics of the business.
Industry RankSector Rank
Current Ratio 1.93
Quick Ratio 0.97
NORBT.OL Yearly Current Assets VS Current LiabilitesNORBT.OL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

9

3. Growth

3.1 Past

NORBT shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 103.96%, which is quite impressive.
The Earnings Per Share has been growing by 22.16% on average over the past years. This is a very strong growth
The Revenue has grown by 15.31% in the past year. This is quite good.
The Revenue has been growing by 21.25% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)103.96%
EPS 3Y67.64%
EPS 5Y22.16%
EPS Q2Q%71.67%
Revenue 1Y (TTM)15.31%
Revenue growth 3Y30.51%
Revenue growth 5Y21.25%
Sales Q2Q%63.38%

3.2 Future

Based on estimates for the next years, NORBT will show a very strong growth in Earnings Per Share. The EPS will grow by 32.75% on average per year.
The Revenue is expected to grow by 20.89% on average over the next years. This is a very strong growth
EPS Next Y92.83%
EPS Next 2Y52.04%
EPS Next 3Y37.23%
EPS Next 5Y32.75%
Revenue Next Year46.64%
Revenue Next 2Y29.96%
Revenue Next 3Y23.86%
Revenue Next 5Y20.89%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
NORBT.OL Yearly Revenue VS EstimatesNORBT.OL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 1B 2B 3B
NORBT.OL Yearly EPS VS EstimatesNORBT.OL Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2 4 6 8 10

5

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 32.28, which means the current valuation is very expensive for NORBT.
NORBT's Price/Earnings is on the same level as the industry average.
Compared to an average S&P500 Price/Earnings ratio of 27.32, NORBT is valued at the same level.
With a Price/Forward Earnings ratio of 20.25, NORBT is valued on the expensive side.
The rest of the industry has a similar Price/Forward Earnings ratio as NORBT.
When comparing the Price/Forward Earnings ratio of NORBT to the average of the S&P500 Index (22.89), we can say NORBT is valued inline with the index average.
Industry RankSector Rank
PE 32.28
Fwd PE 20.25
NORBT.OL Price Earnings VS Forward Price EarningsNORBT.OL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

NORBT's Enterprise Value to EBITDA ratio is in line with the industry average.
The rest of the industry has a similar Price/Free Cash Flow ratio as NORBT.
Industry RankSector Rank
P/FCF 36.91
EV/EBITDA 21.19
NORBT.OL Per share dataNORBT.OL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20 25

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
The excellent profitability rating of NORBT may justify a higher PE ratio.
A more expensive valuation may be justified as NORBT's earnings are expected to grow with 37.23% in the coming years.
PEG (NY)0.35
PEG (5Y)1.46
EPS Next 2Y52.04%
EPS Next 3Y37.23%

4

5. Dividend

5.1 Amount

NORBT has a Yearly Dividend Yield of 1.53%.
Compared to an average industry Dividend Yield of 2.82, NORBT has a dividend in line with its industry peers.
NORBT's Dividend Yield is slightly below the S&P500 average, which is at 2.42.
Industry RankSector Rank
Dividend Yield 1.53%

5.2 History

The dividend of NORBT has a limited annual growth rate of 5.27%.
Dividend Growth(5Y)5.27%
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

50.50% of the earnings are spent on dividend by NORBT. This is a bit on the high side, but may be sustainable.
The dividend of NORBT is growing, but earnings are growing more, so the dividend growth is sustainable.
DP50.5%
EPS Next 2Y52.04%
EPS Next 3Y37.23%
NORBT.OL Yearly Income VS Free CF VS DividendNORBT.OL Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2018 2019 2020 2021 2022 2023 2024 0 100M 200M
NORBT.OL Dividend Payout.NORBT.OL Dividend Payout, showing the Payout Ratio.NORBT.OL Dividend Payout.PayoutRetained Earnings

NORBIT ASA

OSL:NORBT (9/26/2025, 7:00:00 PM)

183

-7.8 (-4.09%)

Chartmill FA Rating
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryElectronic Equipment, Instruments & Components
Earnings (Last)08-14 2025-08-14/bmo
Earnings (Next)N/A N/A
Inst Owners19.65%
Inst Owner ChangeN/A
Ins Owners1.88%
Ins Owner ChangeN/A
Market Cap11.70B
Analysts84
Price Target234.6 (28.2%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.53%
Yearly Dividend2.47
Dividend Growth(5Y)5.27%
DP50.5%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)9.75%
Min EPS beat(2)-5.2%
Max EPS beat(2)24.7%
EPS beat(4)2
Avg EPS beat(4)7.8%
Min EPS beat(4)-38.62%
Max EPS beat(4)50.33%
EPS beat(8)4
Avg EPS beat(8)0.21%
EPS beat(12)7
Avg EPS beat(12)4.93%
EPS beat(16)8
Avg EPS beat(16)6.28%
Revenue beat(2)0
Avg Revenue beat(2)-2.1%
Min Revenue beat(2)-2.46%
Max Revenue beat(2)-1.75%
Revenue beat(4)1
Avg Revenue beat(4)-4.48%
Min Revenue beat(4)-15.14%
Max Revenue beat(4)1.42%
Revenue beat(8)2
Avg Revenue beat(8)-2.05%
Revenue beat(12)5
Avg Revenue beat(12)1.4%
Revenue beat(16)8
Avg Revenue beat(16)1.8%
PT rev (1m)0%
PT rev (3m)17.95%
EPS NQ rev (1m)0%
EPS NQ rev (3m)43.46%
EPS NY rev (1m)4.13%
EPS NY rev (3m)24.17%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.7%
Revenue NY rev (1m)0%
Revenue NY rev (3m)9.31%
Valuation
Industry RankSector Rank
PE 32.28
Fwd PE 20.25
P/S 6.26
P/FCF 36.91
P/OCF 24.46
P/B 9.43
P/tB 36
EV/EBITDA 21.19
EPS(TTM)5.67
EY3.1%
EPS(NY)9.04
Fwd EY4.94%
FCF(TTM)4.96
FCFY2.71%
OCF(TTM)7.48
OCFY4.09%
SpS29.22
BVpS19.41
TBVpS5.08
PEG (NY)0.35
PEG (5Y)1.46
Profitability
Industry RankSector Rank
ROA 12.76%
ROE 24.39%
ROCE 24.23%
ROIC 18.38%
ROICexc 21.26%
ROICexgc 52.57%
OM 23.08%
PM (TTM) 16.2%
GM 61.99%
FCFM 16.97%
ROA(3y)10.75%
ROA(5y)8.25%
ROE(3y)20.73%
ROE(5y)15.61%
ROIC(3y)17.33%
ROIC(5y)13.48%
ROICexc(3y)18.7%
ROICexc(5y)14.35%
ROICexgc(3y)38.39%
ROICexgc(5y)28.66%
ROCE(3y)22.85%
ROCE(5y)17.76%
ROICexcg growth 3Y38.91%
ROICexcg growth 5Y14.38%
ROICexc growth 3Y27.68%
ROICexc growth 5Y2.09%
OM growth 3Y29.01%
OM growth 5Y7.42%
PM growth 3Y31.71%
PM growth 5Y3.74%
GM growth 3Y3.52%
GM growth 5Y1.89%
F-Score6
Asset Turnover0.79
Health
Industry RankSector Rank
Debt/Equity 0.41
Debt/FCF 1.68
Debt/EBITDA 0.9
Cap/Depr 119.57%
Cap/Sales 8.63%
Interest Coverage 250
Cash Conversion 84.49%
Profit Quality 104.72%
Current Ratio 1.93
Quick Ratio 0.97
Altman-Z 8.22
F-Score6
WACC8.36%
ROIC/WACC2.2
Cap/Depr(3y)104.85%
Cap/Depr(5y)141.79%
Cap/Sales(3y)7.72%
Cap/Sales(5y)11.08%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)103.96%
EPS 3Y67.64%
EPS 5Y22.16%
EPS Q2Q%71.67%
EPS Next Y92.83%
EPS Next 2Y52.04%
EPS Next 3Y37.23%
EPS Next 5Y32.75%
Revenue 1Y (TTM)15.31%
Revenue growth 3Y30.51%
Revenue growth 5Y21.25%
Sales Q2Q%63.38%
Revenue Next Year46.64%
Revenue Next 2Y29.96%
Revenue Next 3Y23.86%
Revenue Next 5Y20.89%
EBIT growth 1Y74.83%
EBIT growth 3Y68.37%
EBIT growth 5Y30.25%
EBIT Next Year125.07%
EBIT Next 3Y41.98%
EBIT Next 5YN/A
FCF growth 1Y252.33%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y169.37%
OCF growth 3Y108.27%
OCF growth 5Y59.9%